BNT162b2 mRNA COVID-19 vaccine three-dose safety and risk of COVID-19 in patients with myasthenia gravis during the alpha, delta, and omicron waves

COVID-19 affects the respiratory parenchyma and may potentially contribute to the tendency of myasthenia gravis (MG) patients to develop respiratory failure. It is, therefore, important to study the safety of vaccines against SARS-CoV-2 and to assess the risk of COVID-19 in MG patients. The safety o...

Descripción completa

Detalles Bibliográficos
Autores principales: Doron, Alon, Piura, Yoav, Vigiser, Ifat, Kolb, Hadar, Regev, Keren, Nesher, Nahum, Karni, Arnon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361942/
https://www.ncbi.nlm.nih.gov/pubmed/35907046
http://dx.doi.org/10.1007/s00415-022-11303-8